Benjamin F. Edwards & Company’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$18K Buy
+1,135
New +$17.9K ﹤0.01% 1573
2016
Q1
Sell
-900
Closed -$18K 1101
2015
Q4
$18K Buy
900
+500
+125% +$12.4K ﹤0.01% 716
2015
Q3
$10K Buy
400
+200
+100% +$5.2K ﹤0.01% 866
2015
Q2
$5K Buy
+200
New +$5.3K ﹤0.01% 1026
2014
Q4
Sell
-3,315
Closed -$91K 1022
2014
Q3
$91K Sell
3,315
-10,405
-76% -$314K 0.02% 411
2014
Q2
$436K Buy
13,720
+4,845
+55% +$144K 0.11% 184
2014
Q1
$229K Buy
8,875
+8,375
+1,675% +$229K 0.06% 268
2013
Q4
$13K Sell
500
-850
-63% -$23.7K ﹤0.01% 604
2013
Q3
$37K Buy
1,350
+1,050
+350% +$33K 0.01% 436
2013
Q2
$11K Buy
+300
New +$10.8K ﹤0.01% 547

Other funds holding CLMT

Benjamin F. Edwards & Company's CLMT Position: Q2 2024 in Review

Benjamin F. Edwards & Company opened a new position in Calumet Specialty Products (CLMT) in Q2 2024: 1,135 shares worth $18K. The stake represents ﹤0.01% of the portfolio and ranks #1573 among its holdings. This is a return to the name: Benjamin F. Edwards & Company previously reported a position in CLMT as recently as Q4 2015.

Benjamin F. Edwards & Company first reported a position in CLMT in Q2 2013 and has held it in 10 quarters since. The position peaked at $436K in Q2 2014. 69 funds tracked by Wall St. Rank hold CLMT as of Q2 2024.

  • Benjamin F. Edwards & Company held 1,135 shares of Calumet Specialty Products worth $18K as of Q2 2024.
  • Calumet Specialty Products was a new Benjamin F. Edwards & Company position in Q2 2024.
  • Calumet Specialty Products made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1573 holding.
  • Benjamin F. Edwards & Company first reported a position in Calumet Specialty Products in Q2 2013 and has held it in 10 quarters since.
  • Benjamin F. Edwards & Company's Calumet Specialty Products position peaked at $436K in Q2 2014.
  • 69 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.